Equities

Fisher & Paykel Healthcare Corporation Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Fisher & Paykel Healthcare Corporation Ltd

Actions
Health CareMedical Equipment and Services
  • Price (NZD)36.63
  • Today's Change0.23 / 0.63%
  • Shares traded52.13k
  • 1 Year change+22.92%
  • Beta1.5154
Data delayed at least 20 minutes, as of Jul 04 2025 03:15 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India, and others.

  • Revenue in NZD (TTM)2.02bn
  • Net income in NZD377.20m
  • Incorporated1954
  • Employees7.51k
  • Location
    Fisher & Paykel Healthcare Corporation Ltd15 Maurice Paykel Place, East Tamaki,AUCKLAND 2013New ZealandNZL
  • Phone+64 95740100
  • Fax+64 95740158
  • Websitehttps://www.fphcare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sysmex Corp5.81bn613.28m18.09bn10.53k29.233.3817.103.1186.0786.07815.75743.710.79222.943.0948,290,420.008.348.7010.2910.9453.4752.4710.5310.982.3010.860.123538.1110.2110.998.129.0013.545.92
Cochlear Ltd2.50bn400.49m21.32bn5.00k53.4710.5743.258.545.645.6435.1528.540.86861.434.87461,780.0013.948.5517.7611.1575.7575.0516.0511.981.52--0.116691.1415.479.4018.705.22-4.764.44
Fisher & Paykel Healthcare Corporatn Ltd2.02bn377.20m21.98bn7.51k58.6911.6242.5210.880.63890.63893.423.230.83642.267.19269,251.3015.6115.5819.1118.8062.8861.7018.6618.461.1880.890.07558.5915.969.85184.465.60-9.619.10
Olympus Corp11.40bn1.35bn22.27bn29.30k16.572.5710.571.95103.21103.27870.68666.540.67231.664.9634,042,120.007.946.7411.179.5168.5566.8511.8110.691.1663.110.233621.136.535.72342.6914.22-0.219414.87
Shanghai United Img Hlthcare Co Ltd2.39bn290.69m23.82bn8.17k81.555.13--9.971.551.5512.7324.610.38481.042.391,275,857.004.608.246.0511.8748.0748.3411.9416.402.00--0.05957.41-9.7328.16-36.08--24.57--
Pro Medicus Ltd206.31m106.24m32.20bn79.00303.98134.10282.27156.100.93820.93821.822.130.75094.044.03--38.6732.1943.6037.8499.8599.5851.5047.157.041,455.250.008241.4430.6327.0036.5234.05-2.3837.97
Data as of Jul 04 2025. Currency figures normalised to Fisher & Paykel Healthcare Corporation Ltd's reporting currency: New Zealand Dollar NZD

Institutional shareholders

20.99%Per cent of shares held by top holders
HolderShares% Held
Hyperion Asset Management Ltd.as of 27 Feb 202528.70m4.90%
The Vanguard Group, Inc.as of 04 Jun 202521.18m3.61%
First Sentier Investors (Australia) IM Ltd.as of 28 Feb 202514.69m2.51%
Guardians of New Zealand Superannuationas of 30 Jun 202313.09m2.23%
BlackRock Fund Advisorsas of 05 Jun 202510.88m1.86%
Norges Bank Investment Managementas of 30 Jun 20249.98m1.70%
First Sentier Investors (Hong Kong) Ltd.as of 28 Feb 20256.82m1.16%
Geode Capital Management LLCas of 26 Jun 20256.37m1.09%
First Sentier Investors (Singapore)as of 28 Feb 20256.24m1.07%
Smartshares Ltd.as of 30 May 20255.09m0.87%
More ▼
Data from 30 Jun 2023 - 19 Jun 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.